ÐÓ°ÉÂÛ̳

Skip to main content
Quest Diagnostics

Correlates of Immunity in SARS-CoV-2 Post-Vaccine Infectious in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study

IDWeek 2022

Washington, DC, October 19 - 23 , 2022

Poster presentation:?

Authors:?Goguet E, Weiss CD, Olsen CH, Powers JH III, Coggins SA, Tribble DR, Davies J, Meyer WA, Ansari S, Illinik L, Lusvarghi S, Sanchez Edwards M, Jackson-Thompson BM, Hollis-Perry M, Pollet S, Wang G, Alcorta Y, Wong MA, Saunders D, Mohammed R, Ortega O, Parmelee E, Lindrose AR, Haines-Hull H, Moser MS, Samuels EC, Tso MS, Graydon E, Malloy AM, Schully KL, Burgess TH, Broder CC, Laing ED, Mitre E

Specialties:?Infectious Disease, Immunology, ÐÓ°ÉÂÛ̳-19

Our company

Quest? is the brand name used for services offered by ÐÓ°ÉÂÛ̳ and its affiliated companies. ÐÓ°ÉÂÛ̳ and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.? Other affiliates operated under the Quest? brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.?

?

Quest?, Quest Diagnostics?, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks¡ª? and ?¡ªare the property of their respective owners. ? 2025 ÐÓ°ÉÂÛ̳. All rights reserved. Image content features models and is intended for illustrative purposes only.